Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A. O’Halloran(St. Vincent's University Hospital), Patricia Segura Nunez(Hospital Nacional Cayetano Heredia), Gerardo Capo(Trinitas Regional Medical Center), Radica Z. Alicic(Providence Health & Services), Stacey J. Adam(Foundation for the National Institutes of Health), Christopher Palma(University of Rochester), Michael A. Proschan(National Institute of Allergy and Infectious Diseases), Emily R. Ko(Duke University Health System), Eduardo Sprinz(Hospital de Clínicas de Porto Alegre), Matthias Salathé(University of Miami), Thomas F. Patterson(National Institute of Allergy and Infectious Diseases), Anne M. Lachiewicz(University of North Carolina at Chapel Hill), Lisa M. LaVange(University of North Carolina at Chapel Hill), Richard Melsheimer(ISA Pharmaceuticals (Netherlands)), Adriana M. Rauseo(Washington University in St. Louis), Eyal Kedar(St. Lawrence University), Maria Patelli Juliani Souza Lima(Hospital e Maternidade Celso Pierro), Esteban C. Nannini(Centro Científico Tecnológico - Santa Fe), Samuel A. Bozzette(RAND Corporation), P. Brian Smith(Clinical Research Institute), Sabina Mendivil Tuchia de Tai, Susan Halabi(Duke Medical Center), Steven E. McNulty, William G. Powderly(Washington University in St. Louis), Cynthia Boucher(National Center for Advancing Translational Sciences), Matthew W. McCarthy(Cornell University), Pearl Zakroysky(Duke University), Sandra Butler(Technical Resources International (United States)), John Blamoun(MidMichigan Medical Center - Midland), Akram Khan(Oregon Health & Science University), Alfredo J Mena Lora(University of Illinois Chicago), Kevin J. Anstrom(University of North Carolina at Chapel Hill), Daniel González(University of North Carolina at Chapel Hill), Horacio Ariza, Daniel K. Benjamin(Duke University), Analía Mykietiuk(Instituto Médico Platense), Soju Chang(National Center for Advancing Translational Sciences), Reynold A. Panettieri(Rutgers, The State University of New Jersey), Cameron R. Wolfe(Duke Medical Center), Martin Maillo(Centro Científico Tecnológico - Santa Fe), Britta Witting(Cornell University), Jane Atkinson(Office of Infectious Diseases)
Cited by 9
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k